American Shared Hospital Services (AMS)
(Delayed Data from AMEX)
$3.14 USD
-0.06 (-1.88%)
Updated Oct 4, 2024 03:58 PM ET
After-Market: $3.15 +0.01 (0.32%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for American Shared Hospital Services falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 21 | 20 | 18 | 18 | 21 |
Cost Of Goods | 12 | 11 | 11 | 13 | 14 |
Gross Profit | 9 | 8 | 7 | 4 | 7 |
Selling & Adminstrative & Depr. & Amort Expenses | 8 | 5 | 5 | 13 | 4 |
Income After Depreciation & Amortization | 1 | 3 | 2 | -8 | 3 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 1 | 1 | 1 | 1 | 1 |
Pretax Income | 1 | 3 | 1 | -9 | 2 |
Income Taxes | 0 | 1 | 0 | -2 | 0 |
Minority Interest | 0 | 0 | 0 | -1 | 1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 0 | 2 | 1 | -8 | 1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1 | 1 | 0 | -7 | 1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 7 | 8 | 7 | -1 | 10 |
Depreciation & Amortization (Cash Flow) | 5 | 5 | 5 | 7 | 7 |
Income After Depreciation & Amortization | 1 | 3 | 2 | -8 | 3 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 6.39 | 6.30 | 6.47 | 6.19 | 5.93 |
Diluted EPS Before Non-Recurring Items | 0.19 | 0.21 | 0.10 | -0.08 | 0.11 |
Diluted Net EPS (GAAP) | 0.10 | 0.21 | 0.03 | -1.14 | 0.11 |
Fiscal Year end for American Shared Hospital Services falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 7.06 | 5.22 | 5.70 | 5.13 | 5.57 |
Cost Of Goods | 4.59 | 3.07 | 2.88 | 3.03 | 3.05 |
Gross Profit | 2.47 | 2.14 | 2.82 | 2.10 | 2.52 |
SG&A, R&D, and Dept/Amort Expenses | 2.08 | 1.88 | 2.12 | 1.74 | 2.57 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.39 | 0.26 | 0.70 | 0.36 | -0.05 |
Non-Operating Income | 3.74 | 0.11 | 0.11 | 0.14 | 0.11 |
Interest Expense | 0.39 | 0.35 | 0.29 | 0.28 | 0.28 |
Pretax Income | 3.74 | 0.02 | 0.52 | 0.23 | -0.21 |
Income Taxes | -0.03 | -0.04 | 0.34 | 0.06 | -0.04 |
Minority Interest | 0.17 | -0.05 | -0.24 | 0.05 | -0.07 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 3.77 | 0.07 | 0.18 | 0.17 | -0.18 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 3.60 | 0.12 | 0.42 | 0.12 | -0.11 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 6.58 | 6.45 | 6.55 | 6.43 | 6.34 |
Diluted EPS Before Non-Recurring Items | 0.13 | 0.02 | 0.06 | 0.02 | 0.07 |
Diluted Net EPS (GAAP) | 0.55 | 0.02 | 0.07 | 0.02 | -0.02 |